Synlab’s Initial Public Offering

Poellath advised Synlab’s board of directors on the deal. Clifford Chance has advised SYNLAB, Europe’s leading medical laboratory and diagnostic services company, and its majority shareholders...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Eckert & Ziegler BEBIG GmbH’s Spin-Off of Its HDR Business And Sale of Majority Stake in BEBIG Medical GmbH to TCL

Poellath and Wuertenberger advised Eckert & Ziegler BEBIG GmbH and Eckert & Ziegler Strahlen- und Medizintechnik AG, while Huth Dietrich Hahn Rechtsanwälte advised TCL. Eckert &...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Eckert & Ziegler BEBIG GmbH’s Spin-Off of Its HDR Business And Sale of Majority Stake in BEBIG Medical GmbH to TCL

Poellath and Wuertenberger advised Eckert & Ziegler BEBIG GmbH and Eckert & Ziegler Strahlen- und Medizintechnik AG, while Huth Dietrich Hahn Rechtsanwälte advised TCL. Eckert &...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here